Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Mar;91(2):F156.
doi: 10.1136/adc.2005.084699.

Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe?

P M Loughnan
Comment

Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe?

P M Loughnan. Arch Dis Child Fetal Neonatal Ed. 2006 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

Comment on

References

    1. Nestaas E, Bangstad H ‐ J, Sandvi K L.et al Aminoglycoside extended interval dosing in neonates is safe and effective: a meta‐analysis. Arch Dis Child Fetal Neonatal Ed 200590F294–F300. - PMC - PubMed
    1. Benet L Z, Kroetz D L, Sheiner L B. Pharmacokinetics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 9th ed. New York: McGraw‐Hill, 199617–27.
    1. Lundergan F S, Glasscock G F, Kim E H.et al Once‐daily gentamicin dosing in newborn infants. Pediatrics 19991031228–1234. - PubMed
    1. Kotze A, Bartel P R, Sommers De K. Once versus twice daily amikacin in neonates: prospective study on toxicity. J Paediatr Child Health 199935283–286. - PubMed
    1. Finitzo‐Hieber T, McCracken G H, Jr, Roeser R J.et al Ototoxicity in neonates treated with gentamicin and kanamicin: results of a four‐year controlled follow‐up study. Pediatrics 197963443–450. - PubMed

MeSH terms